414 related articles for article (PubMed ID: 33000254)
1. Long noncoding RNAs, ENST00000598996 and ENST00000524265, are correlated with favorable prognosis and act as potential tumor suppressors in bladder cancer.
Shen C; Wang Y; Wu Z; Da L; Gao S; Xie L; Qie Y; Wang Y; Zhang Z; Tian D; Hu H
Oncol Rep; 2020 Nov; 44(5):1831-1850. PubMed ID: 33000254
[TBL] [Abstract][Full Text] [Related]
2. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
3. Downregulated hsa_circ_0077837 and hsa_circ_0004826, facilitate bladder cancer progression and predict poor prognosis for bladder cancer patients.
Shen C; Wu Z; Wang Y; Gao S; Da L; Xie L; Qie Y; Tian D; Hu H
Cancer Med; 2020 Jun; 9(11):3885-3903. PubMed ID: 32250047
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of the lncRNA‑associated competing endogenous RNA network in breast cancer.
Wang JJ; Huang YQ; Song W; Li YF; Wang H; Wang WJ; Huang M
Oncol Rep; 2019 Dec; 42(6):2572-2582. PubMed ID: 31638237
[TBL] [Abstract][Full Text] [Related]
5. Long Non-Coding RNA Expression Profiles for the Characterization of Different Bladder Cancer Grade.
Cao YP; Zhou J; Li WJ; Shao Y; Zheng SY; Tian T; Xie KP; Yan X
Cell Physiol Biochem; 2018; 50(3):1154-1163. PubMed ID: 30355928
[TBL] [Abstract][Full Text] [Related]
6. Lnc-MUC20-9 binds to ROCK1 and functions as a tumor suppressor in bladder cancer.
Dai R; Zhou Y; Chen Z; Zou Z; Pan Z; Liu P; Gao X
J Cell Biochem; 2020 Oct; 121(10):4214-4225. PubMed ID: 31898364
[TBL] [Abstract][Full Text] [Related]
7. A robust signature of immune-related long non-coding RNA to predict the prognosis of bladder cancer.
Lai C; Wu Z; Li Z; Yu H; Li K; Tang Z; Liu C; Xu K
Cancer Med; 2021 Sep; 10(18):6534-6545. PubMed ID: 34374227
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of long non‑coding RNA n346372 in bladder cancer tissues is associated with a poor prognosis.
Liu A; Zhang Z; Xu W; Qin S; Hua M; Zeng S; Xu C
Mol Med Rep; 2018 Dec; 18(6):5437-5444. PubMed ID: 30365104
[TBL] [Abstract][Full Text] [Related]
9. RNA-Sequencing Data Reveal a Prognostic Four-lncRNA-Based Risk Score for Bladder Urothelial Carcinoma: An in Silico Update.
He RQ; Huang ZG; Li TY; Wei YP; Chen G; Lin XG; Wang QY
Cell Physiol Biochem; 2018; 50(4):1474-1495. PubMed ID: 30359990
[TBL] [Abstract][Full Text] [Related]
10. LncRNA PCAT6: A potential biomarker for diagnosis and prognosis of bladder cancer.
Zhang D; Du D; Yi S; Li X
Ann Diagn Pathol; 2020 Dec; 49():151642. PubMed ID: 33142195
[TBL] [Abstract][Full Text] [Related]
11. A prognostic index based on a fourteen long non-coding RNA signature to predict the recurrence-free survival for muscle-invasive bladder cancer patients.
Zhang X; Zhang M; Zhang X; Zhu X; Wang J
BMC Med Inform Decis Mak; 2020 Jul; 20(Suppl 3):136. PubMed ID: 32646427
[TBL] [Abstract][Full Text] [Related]
12. Explore prognostic biomarker of bladder cancer based on competing endogenous network.
Li F; Guo H; Liu B; Liu N; Xu Z; Wang Y; Zhou H
Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33169791
[TBL] [Abstract][Full Text] [Related]
13. High expression of long noncoding RNA NORAD indicates a poor prognosis and promotes clinical progression and metastasis in bladder cancer.
Li Q; Li C; Chen J; Liu P; Cui Y; Zhou X; Li H; Zu X
Urol Oncol; 2018 Jun; 36(6):310.e15-310.e22. PubMed ID: 29605462
[TBL] [Abstract][Full Text] [Related]
14. Integrated analysis of a ceRNA network reveals potential prognostic lncRNAs in gastric cancer.
Qi M; Yu B; Yu H; Li F
Cancer Med; 2020 Mar; 9(5):1798-1817. PubMed ID: 31923354
[TBL] [Abstract][Full Text] [Related]
15. Transcriptomic analysis of high-throughput sequencing about circRNA, lncRNA and mRNA in bladder cancer.
Li M; Liu Y; Zhang X; Liu J; Wang P
Gene; 2018 Nov; 677():189-197. PubMed ID: 30025927
[TBL] [Abstract][Full Text] [Related]
16. Profile and validation of dysregulated long non‑coding RNAs and mRNAs in ovarian cancer.
Lu YM; Wang Y; Liu SQ; Zhou MY; Guo YR
Oncol Rep; 2018 Nov; 40(5):2964-2976. PubMed ID: 30132558
[TBL] [Abstract][Full Text] [Related]
17. Pathway analysis of a genome‑wide association study on a long non‑coding RNA expression profile in oral squamous cell carcinoma.
Qiu YL; Liu YH; Ban JD; Wang WJ; Han M; Kong P; Li BH
Oncol Rep; 2019 Feb; 41(2):895-907. PubMed ID: 30431131
[TBL] [Abstract][Full Text] [Related]
18. Cell-free lncRNA expression signatures in urine serve as novel non-invasive biomarkers for diagnosis and recurrence prediction of bladder cancer.
Du L; Duan W; Jiang X; Zhao L; Li J; Wang R; Yan S; Xie Y; Yan K; Wang Q; Wang L; Yang Y; Wang C
J Cell Mol Med; 2018 May; 22(5):2838-2845. PubMed ID: 29516641
[TBL] [Abstract][Full Text] [Related]
19. The prognostic significance of long noncoding RNAs in bladder cancer: A meta-analysis.
Xia Y; Liu Z; Yu W; Zhou S; Shao L; Song W; Liu M
PLoS One; 2018; 13(6):e0198602. PubMed ID: 29870555
[TBL] [Abstract][Full Text] [Related]
20. Expression signatures of exosomal long non-coding RNAs in urine serve as novel non-invasive biomarkers for diagnosis and recurrence prediction of bladder cancer.
Zhan Y; Du L; Wang L; Jiang X; Zhang S; Li J; Yan K; Duan W; Zhao Y; Wang L; Wang Y; Wang C
Mol Cancer; 2018 Sep; 17(1):142. PubMed ID: 30268126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]